Enzymatic Biosensors are innovative analytical devices designed to detect and quantify specific substances by leveraging the catalytic activity of enzymes. These biosensors typically consist of a biorecognition element (enzyme), a transducer, and a signal-processing system. Enzymes act as molecular catalysts, facilitating biochemical reactions with high specificity and sensitivity. The transducer converts the enzymatic reaction into a measurable signal, such as an electrical, optical, or electrochemical output. Enzymatic biosensors find widespread application in various fields, including medical diagnostics, environmental monitoring, and food safety. Their specificity allows for the precise detection of target analytes, ranging from glucose and cholesterol in clinical settings to pollutants in environmental samples. The integration of nanotechnology and microfabrication techniques has enhanced the performance and miniaturization of enzymatic biosensors. These devices offer rapid and real-time detection capabilities, making them invaluable for point-of-care diagnostics and continuous monitoring. Challenges in enzymatic biosensor development include stability and immobilization of enzymes, but ongoing research aims to address these issues. The versatility and accuracy of enzymatic biosensors contribute to their increasing importance in advancing diagnostics and monitoring applications across diverse domains.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy